1.  Thiopoietins: a new generation of immunomodulators.

G. Castello.


2.  Instruction on medical application of Glutoxim.



3.  A study of hemostimulating properties of Glutoxim in non-small cell lung carcinoma (NSCLC) patients undergoing cytostatic chemotherapy.

V.A.Gorbunova, N.V.Mindra, L.A.Kozhemyakin, I.V.Ose.
Russian Academy of Medical Sciences Oncology Research Center, Moscow, GSC “VAM – Research Laboratories, St.-Petersburg, GSC “PHARMA VAM”, Moscow.


4.  Experience of using Glutoxim in oncological patients.

S.V.Odintsov, A.P.Nikolaev, N.N.Vinogradova.
Central Clinical Hospital, Medical center at the RF Presidential Administration, Moscow.


5.  Glutoxim mechanisms of action.


6.  Glutoxim, a disulfide-containing hexapeptide, ensures a favorable survival outcome and better tolerability of chemotherapy in patients with stage III-IV non-small-cell lung cancer.

Kozhemyakin LA., Smirnov A.I., Orlov S.V. Pulmonology Research Institute of Saint-Petersburg State Pavlov Medical University, St-Petersburg, Russia; Novelos Therapeutics, Inc., USA.